Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
283,618
-
Share change
-
+61,922
-
Total reported value
-
$1,077,000
-
Price per share
-
$3.79
-
Number of holders
-
17
-
Value change
-
+$263,027
-
Number of buys
-
8
-
Number of sells
-
4
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q1 2021
As of 31 Mar 2021 Scinai Immunotherapeutics Ltd. - ADSs (BVXV) had 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 283,618 shares of stock of the company.
Largest 10 holders included STATE STREET CORP, MORGAN STANLEY, HRT FINANCIAL LP, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, TRUE Private Wealth Advisors, TWO SIGMA ADVISERS, LP, and ARK Investment Management LLC.
This table shows 17 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.